Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842) [Phase 3]
A Phase 3 double-blind trial evaluating sitagliptin added to ipragliflozin in Japanese adults with type 2 diabetes and inadequate glycemic c…
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals [Phase 3]
A Phase 3 trial testing whether vitamin D supplementation reduces the risk of developing Type 2 Diabetes Mellitus in high-risk individuals h…
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment [NA]
Clinical trial update for PRuDENTE focusing on diabetes prevention through exercise, nutrition, and treatment in people with Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey
This clinical trial update reports a retrospective cohort study from Turkey evaluating the use of dapagliflozin in patients with type 2 diab…
-
FDA label_change · 2018-03-06FDA Approved: STEGLUJAN — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Steglujan (ertugliflozin and sitagliptin) from Merck Sharp & Dohme LLC, indicating changes t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-03-06FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for FIASP (insulin aspart injection) by Novo Nordisk. The approval results in an updated labeling fo…
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms [NA]
This update describes a completed clinical study assessing the cardiovascular effects and potential blood pressure lowering effect of exenat…
-
CLINICAL_TRIALS research · 2018-03-06Clinical Trial Update: Validation of an Integrated Attention Model for Patients With Type 2 Diabetes [NA]
An ongoing clinical trial at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran is evaluating an integrated attention model…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II [NA]
A completed clinical trial evaluating an artificial saliva spray reported a reduction in xerostomia symptoms in individuals with type 2 diab…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study [NA]
This completed clinical trial evaluated whether reducing carbohydrate intake as a macronutrient-based dietary strategy can improve glycemic …
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: Insulin Resistance and Insulin Secretion [NA]
A clinical trial investigating insulin resistance and insulin secretion in Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS research · 2018-03-02Clinical Trial Update: Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes [NA]
Bispebjerg Hospital's trial examining a low-carbohydrate diet for Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: The Diabetes TeleCare Study [NA]
This entry notes that the Diabetes TeleCare Study sponsored by the NIDDK has completed, evaluating telecare approaches for Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Diabetes Prevention Program [Phase 3]
The Diabetes Prevention Program, a Phase 3 clinical trial sponsored by NIDDK, has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus [NA]
This completed clinical trial evaluated the effects of resveratrol on endothelial function in individuals with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus [NA]
Completed clinical trial examining dose-dependent effects of erythritol on endothelial function in individuals with Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced Hypoglycaemia [NA]
A completed clinical trial evaluated QT interval abnormalities in patients with type 2 diabetes treated with sulfonylureas and examined the …
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards [Phase 4]
A Phase 4 trial comparing basal-bolus insulin therapy to sliding-scale insulin in hospitalized patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: The Effects of Vitamin D Supplementation on Patients With Type 2 Diabetes and Vitamin D Deficiency [Phase 4]
This Phase 4 clinical trial update reports on the effects of vitamin D supplementation in patients with type 2 diabetes mellitus and vitamin…
-
CLINICAL_TRIALS research · 2018-02-27Clinical Trial Update: The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic Patients [NA]
This document provides an update on a clinical trial evaluating whether daily consumption of extra virgin olive oil affects blood glucose in…
-
CLINICAL_TRIALS research · 2018-02-26Clinical Trial Update: Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes [Phase 4]
Phase 4 clinical trial update assessing the impact of dapagliflozin on cardio-metabolic risk factors in adults with Type 2 Diabetes Mellitus…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients. [NA]
This completed clinical trial evaluated a Motivational Interviewing–informed text messaging program aimed at lowering blood sugar in adults …
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver [Phase 2]
Phase 2 trial evaluating polyunsaturated fatty acids for fatty liver in diabetes has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Treatment of Diabetes After Gastric Bypass With Sitagliptin [NA]
This clinical trial update reports results of using sitagliptin to treat Type 2 diabetes after gastric bypass surgery.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study) [Phase 3]
Phase 3 trial evaluating gemigliptin added to insulin with or without metformin in type 2 diabetes completed.